Centessa Pharmaceuticals scales 6% as Director buys stock worth $800K
Dec. 01, 2021 2:47 PM ETCentessa Pharmaceuticals plc (CNTA)By: Manshi Mamtora, CFA
- Centessa Pharmaceuticals (CNTA +6.1%) Director, Rubertis Francesco De buys 68,523 shares worth $800K.
- The price ranges from $11.33 - $11.70.
- Currently, the stock trades at
- Form 4
- The stock has market cap of ~$1B and has dropped about 42% since inception.